Latest Neuroprosthetics Stories

Neuromodulation Market (Deep Brain Stimulation) to Reach $6.8 Billion By 2017 - by MarketsandMarkets

2013-01-28 23:01:06

[193 Pages Report] Neuromodulation devices market report categorizes the global market of Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic Stimulation by procedure, technology, and application. (PRWEB) January 28, 2013 The “Neuromodulation Market – [Spinal Cord Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic...

NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders

2013-01-22 08:29:46

LOS ANGELES, Jan. 22, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California -based medical device company, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/898,686 entitled "Devices, Systems and Methods For Treatment of Neuropsychiatric Disorders." The patent application, exclusively licensed to NeuroSigma, is owned by The Regents of the University of California (Regents) as a result of research...

Reliable Information on Implants Now Available in Just Launched Website Myfreeimplants.info.

2013-01-21 23:03:59

Well known online marketing company Internet Marketing Services has just announced the launch of yet another new website. The new website My free implants discusses all about different types of implants, their uses, and most authentic sources (PRWEB) January 21, 2013 It is finally possible to find out all relevant details about all types of implants, thanks to the recently launched website My free implants. This extremely useful online platform has been introduced by eminent online...

Cochlear Americas Announces 2013 Graeme Clark and Anders Tjellstrom Scholarship Winners

2013-01-21 12:23:31

CENTENNIAL, Colo., Jan. 21, 2013 /PRNewswire/ -- Cochlear Americas, the global leader in implantable hearing solutions, announced today the winners of the 11(th) annual Graeme Clark and the second annual Anders Tjellstrom Scholarships. Named after two pioneers of the hearing implant industry, the 2013 scholarships recognize Cochlear(TM) Nucleus® Cochlear Implant and Baha® System recipients who are not only academically gifted, but have demonstrated a commitment to leadership and...

Global Neuromodulation Market Worth $6.8 Billion By 2017

2013-01-14 02:29:16

DALLAS, January 14, 2013 /PRNewswire/ -- The "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World. Browse market 93 data tables, 4 figures...

Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies

2013-01-09 08:27:29

HOUSTON, Jan. 9, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that Bruce H. KenKnight, Ph.D., joined the company as its Vice President, Emerging Therapies, effective on January 1, 2013. Dr. KenKnight will lead all of the company's emerging therapies programs, including the current clinical evaluation of Autonomic Regulation Therapy, an emerging therapy for treatment of chronic heart failure that incorporates Cyberonics' extensive experience delivering vagus...

Reese Terry, Founder and Former CEO of Cyberonics, Joins ElectroCore Board of Directors

2013-01-04 08:23:34

MORRIS PLAINS, N.J., Jan. 4, 2013 /PRNewswire/ -- ElectroCore®, a company dedicated to developing effective, non-invasive Vagal Nerve Stimulation (nVNS) therapies for serious headache conditions and bronchoconstriction, announced today that Reese Terry, co-founder and former CEO of Cyberonics, Inc., has joined its Board of Directors. Mr. Terry brings more than 25 years of relevant medical device industry experience to ElectroCore. He co-founded Cyberonics in 1987 to develop,...

Medical Bionic Implants: 2017 Market Forecasts to Reach $17.82 Billion in New Research Report at ReportsnReports.com

2012-12-31 05:01:13

RnRMarketResearch.com adds “Medical Bionic Implants Market [Vision, Brain, Heart, Orthopedic & Ear] – Trends & Global Forecasts to 2017” new market research report to its store. Dallas, Texas (PRWEB) December 30, 2012 Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach...

Medical Bionic Implants Market growing at a CAGR of 7.1% to Reach $17.82 Billion by 2017 - New Report by MarketsandMarkets

2012-12-26 05:01:28

[298 Pages Report] Medical Bionic Implants Market research report is mainly targeted toward the key ‘excitable cell’ systems, muscle, and nerve, whose functions are naturally capable of being amended by electrical stimulation. (PRWEB) December 25, 2012 The report“Medical Bionic Implant Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017” analyzes and studies the major market...

Cyberonics Announces 100,000th Patient Implant of VNS Therapy®

2012-12-20 16:25:04

HOUSTON, Dec. 20, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced the 100,000th patient implant of its Vagus Nerve Stimulation (VNS) Therapy system. The announcement comes as Cyberonics recognizes a milestone year marking the 25th anniversary of the company's founding. The VNS Therapy System for the treatment of epilepsy received CE Mark approval 18 years ago, and this year marks the 15th anniversary of approval by the United States Food and Drug...